1620 Investment Advisors’s Humana HUM Stock Holding History

1620 Investment Advisors’s Portfolio HUM Stock Details HUM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1	Closed	-$456	–	723
2024 Q3	$456	Buy	+1	New	+$356	﹤0.01%	679

Other funds holding HUM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Eagle Capital Management (New York) New York $29.8B AUM 12.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

1620 Investment Advisors's HUM Position: Q4 2024 in Review

1620 Investment Advisors sold out of Humana (HUM) in Q4 2024, closing a stake of 1 share — an estimated $456 sold.

1620 Investment Advisors first reported a position in HUM in Q3 2024 and held it in 1 quarter. The position peaked at $456 in Q3 2024. 876 funds tracked by Wall St. Rank hold HUM as of Q4 2024.

1620 Investment Advisors reported no remaining Humana position as of Q4 2024 after selling out during the quarter.
1620 Investment Advisors sold 1 Humana share in Q4 2024, an estimated $456.
1620 Investment Advisors first reported a position in Humana in Q3 2024 and held it in 1 quarter.
1620 Investment Advisors's Humana position peaked at $456 in Q3 2024.
876 funds tracked by Wall St. Rank held Humana as of Q4 2024.

Based on 1620 Investment Advisors's 13F filing for Q4 2024, filed 11 Feb 2025.